Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Polarization and health-related behaviors and outcomes during the COVID-19 pandemic: a systematic review. [PDF]
Ipekci AM +6 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Low‐intervention clinical trials in Spain: Do they progress?
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza +4 more
wiley +1 more source
Late-Stage Capitalism and the Canadian Polycrisis in Living and Working Conditions: Implications for Health and Means of Responding. [PDF]
Amin R, Raphael D.
europepmc +1 more source
Ideological positions in the chilean chamber of deputies (2002-2026): A legislative roll-call dataset. [PDF]
Fábrega J.
europepmc +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
The influence of local officials' promotion incentives on Public-Private Partnership project investment from a political-performance-driven perspective: Empirical evidence from China. [PDF]
Zhang L +5 more
europepmc +1 more source
Reception Baseline Assessment and ‘small acts’ of micro‐resistance
Abstract In September 2021, following the global COVID‐19 pandemic, the Department for Education introduced a national standardised digital Reception Baseline Assessment (RBA) for all English 4‐year‐old children. We analyse RBA and its associated Quality Monitoring Visits, as a further intensification of the new public management of early years ...
Guy Roberts‐Holmes +2 more
wiley +1 more source
Evaluating voter perceptions of political party similarity: A mixed-method study of party positions in Taiwan. [PDF]
Chang SC.
europepmc +1 more source

